The new guidelines have been written to help clinicians in the network follow clear, consistent and evidence-based referral pathways for patients with blood cancers. In doing so we will able to provide more consistent approaches to treatment and reduce unwarranted variations in care, ultimately helping to improve patient outcomes on a wider scale.
The guidelines may be accessed via the links below.
More links section
In February 2022, a large study carried out by researchers from the Manchester University NHS Foundation Trust, identified no association between breast pain (mastalgia) and breast cancer. The relevant paper can be found here.
Despite this, secondary care teams in south east London (SEL) – who work across breast cancer pathways - were reporting a substantial number of women coming into their service with breast pain only. This raised concerns that:
- GPs didn’t feel comfortable managing patients with breast pain in the community and would refer them to secondary care for support.
- Patients were experiencing additional anxiety after being referred to a secondary care pathway.
- An already overloaded One Stop Service with limited imaging capacity were seeing patients unnecessarily.
The South East London Cancer Alliance has been rolling out training sessions across south east London, to assist GPs and healthcare professionals working in primary care with managing patients with breast pain.
SELCA has also created a Mastalgia Management Guide and Q&A, which provides a succinct breakdown of pain management and responses to frequently asked questions from GPs that attended the training sessions.
GPs can also send messages to patients via AccuRx on how to manage their breast pain. Find out more in this guide.